Tag: Biotechnology
Moffitt Cancer Center To Begin 775-Acre Campus In Florida
Construction of the first phase of the Pasco County campus is expected to take five years, and support more than 14,500 jobs in the Tampa Bay region.
North Carolina Is Business Facilities’ 2020 State Of The Year
North Carolina has been named Business Facilities’ 2020 State of the Year, the first time the Tar Heel State has earned the magazine’s top honor.
Biotech: Prosperous Partnerships
From supplements to skincare, it may be surprising to learn that biotech companies are routinely being sought after to help resolve issues such as taste and sustainability.
Revance Therapeutics Relocating Global HQ To Tennessee
The Silicon Valley biotechnology company will invest more than $10 million and create nearly 150 jobs in Nashville over five years.
November / December 2020 Issue (Volume 53, Number 6)
In the November / December 2020 Issue, we unveil our new 21st Century Site Seekers' Guide and Site Seekers’ Guide Featured Locations Directory. Plus an update on economic development's response to COVID-19.
SiO2 To Invest $163M In Alabama Expansion
In response to a contract to supply the federal government with COVID-19 vaccine vials, SiO2 Materials Science will create 220 jobs at its Auburn, AL facility.
Merck Animal Health Investing $100M In Kansas Expansion
The investment will bring capital improvements, expansion of manufacturing capacity and capabilities, and advanced technology to the company's DeSoto, KS operations.
HudsonAlpha Biotechnology Campus Scales Up To Fight COVID-19
The world-class biotech research hub in Huntsville, AL has marshalled its resources to fight the pandemic, with increased lab space.
Grifols Therapeutics Investing $351M In North Carolina Expansion
The global healthcare company will create 300 jobs at a new specialized blood plasma facility and logistics center at its Clayton, NC campus.
Biotech: Finding The DNA For Success
The integration of artificial intelligence within life sciences is making drug discovery and development more innovative, less labor intensive and more cost-effective, says Deloitte’s annual global outlook.
March / April 2020 Issue (Volume 53, Number 2)
The March / April 2020 Issue features the manufacturing and automotive industries. Plus, a look at biotech, food processing, and sustainable development.
UAB Teams With Biotech Firm To Test Potential COVID-19 Vaccine
The University of Alabama at Birmingham is collaborating with biopharm company Altimmune for preclinical testing of a potential vaccine to prevent COVID-19 disease.
Alabama Researchers Join Global Fight Against COVID-19
Scientists and researchers in Alabama are engaged in the global effort to stem threats posed by the novel coronavirus/COVID-19.
Eli Lilly And Company Investing $470M In North Carolina Expansion
Indiana-based Eli Lilly and Company will create more than 460 new jobs at its new manufacturing pharmaceutical facility in Durham, NC.
Growing New Orleans Biotech Companies To Create Over 275 Jobs
The expansions by three biotech firms will create 135 new direct jobs at the University of New Orleans and the New Orleans BioInnovation Center.
Biotech: Finding The DNA For Growth
Life-changing biotech breakthroughs are poised to move out of the labs and into the marketplace, as the emerging science of genomics uses DNA to customize medicine.
March / April 2019 Issue (Volume 52, Number 2)
The March / April 2019 Issue features a look at workforce training programs, manufacturing growth, biotechnology and STEM leaders. Plus, data centers and green development.
U.S. Tax Overhaul Makes Biotech Players Hungry For Big Deals
Industry analysts are predicting that 2018 will turn out to be a banner year for merger and acquisition activity in the biotech/pharma sector, with up to $200 billion in assets changing hands.
March / April 2018 Issue (Volume 51, Number 2)
The March / April 2018 Issue features the emerging cybersecurity sector, an exclusive interview with Kentucky Gov. Matt Bevin, plus a look at biopharm, robots, STEM, data centers, and retail.
Building A Biotech Rebound
A slow start and a dearth of mergers and acquisitions made 2016 a tough year for biotech, but new gene and immuno-therapies are leading the way for a much stronger performance when 2017 results are in.